M. Shu and C. Xiang, “Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways”, Arh Hig Rada Toksikol, vol. 77, no. 1, Mar. 2026, doi: 10.2478/aiht-2026-77-4026.